Weighing the benefits of medications against their potential risks is a common conundrum for many doctors. But, for one common diabetes medication, that decision may have gotten a little easier.

As if cancer treatment isn't rigorous enough, patients are often at risk of additional medical problems for months afterwards. New research has uncovered that some cancer patients face an increased risk of developing blood clots.